DIN 02564009 — TEVIMBRA 100 MG
TEVIMBRA is a solution of Tislelizumab marketed by BEONE MEDICINES I GMBH. The full Tislelizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02564009
- Brand name
- TEVIMBRA
- Active ingredient
- Tislelizumab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BEONE MEDICINES I GMBH
- Health Canada status
- MARKETED
- Drug class
- PD-1 immune checkpoint inhibitor (antineoplastic monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.